RET and Parkinson disease: Taken together, our data support the ongoing clinical phase I trials on PD patients testing AAV-encoded GDNF and phase II trials using recombinant GDNF protein12 and emphasize the central role of Ret in mediating GDNF's survival and regeneration signal in SNpc dopaminergic neurons under neurodegenerative conditions that can cause PD.